ERBB2 and breast cancer: Of the eight BRCA2 mutation-associated breast cancers with information on histopathology, hormone receptor status and HER2 status, five were ER/PR-positive, HER2-negative invasive ductal carcinomas and three were ER/PR-positive, HER2-positive invasive ductal carcinomas.